Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acumen Pharmaceuticals
Acumen Pharmaceuticals
(ABOS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Vorhyaluronidase alfa
hiv infections
Arm1
neoplasms
,
carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
melanoma
,
adenocarcinoma
,
papillary thyroid cancer
,
astrocytoma
,
acinar cell carcinoma
,
mutation rate
,
glioma
Arm2
pancreatic neoplasms
ACU193
alzheimer disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use